<DOC>
	<DOCNO>NCT00960271</DOCNO>
	<brief_summary>This study aim assess role cost-effectiveness EBUS preoperative Non small cell lung cancer stag . This control multicentric study conduct 22 center France . The study design include two prospective phase . In phase 1 , one investigator center prospectively evaluated ability perform EBUS , require goal 9 informative sampling 10 consecutive patient . The phase 2 include medico-economic assessment technique preoperative setting . A maximum 420 patient phase forecast .</brief_summary>
	<brief_title>Evaluation Preoperative Endobronchial Ultrasound ( EBUS ) Non Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>adult patient 18 non small cell lung cancer histologically cytologically proved Clinical Stage IIIA anatomically functionally resectable uncorrected bleeding disorder absence lymphadenopathy superior 1cm small axis CT scan contraindication bronchoscopy extrathoracic intrathoracic metastasis respiratory function test compatible curative resection lung cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>mediastinal lymph node</keyword>
	<keyword>resectable</keyword>
	<keyword>EBUS</keyword>
	<keyword>stage IIIA</keyword>
	<keyword>significant mediastinal lymph node thoracic CT Scan</keyword>
</DOC>